FGF21 is reported to relieve acute or chronic inflammatory diseases by inhibiting the production of IL-17A, which has recently been proven to be associated with human hepatitis, fatty livers, and viral hepatitis-associated HCC [45]. The gene discussed is FGF21; the disease is hepatocellular carcinoma.